Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00149734
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Ondansetron followed by placebo;   Drug: Placebo followed by Ondansetron

Indicates status has not been verified in more than two years